EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data

INTRODUCTION: Brain metastases are one of the leading causes of death from non-small-cell lung cancer (NSCLC). The use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) to treat brain metastases remains controversial. Thus, we performed a pooled analysis of published data...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Yun, Xu, Xiaoling, Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234163/
https://www.ncbi.nlm.nih.gov/pubmed/25419145
http://dx.doi.org/10.2147/OTT.S67586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234163/
https://www.ncbi.nlm.nih.gov/pubmed/25419145
http://dx.doi.org/10.2147/OTT.S67586

Ejemplares similares